| 发明名称 |
SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB |
| 摘要 |
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders. |
| 申请公布号 |
SG11201503695X(A) |
申请公布日期 |
2015.06.29 |
| 申请号 |
SGX11201503695 |
申请日期 |
2013.11.14 |
| 申请人 |
INCYTE CORPORATION |
发明人 |
NI, YONG;PARIKH, BHAVNISH;YELESWARAM, KRISHNASWAMY;ERICKSON-VIITANEN, SUSAN;WILLIAMS, WILLIAM V. |
| 分类号 |
A61K9/20;A61K31/4045 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
